Department of Psychiatry and Behavioral Sciences

Psychiatry Research Institute at Montefiore Einstein (PRIME)

The Psychiatry Research Institute of Montefiore Einstein (PRIME) was established in 2017 to provide an infrastructure for a steadily growing research enterprise. Ongoing and projected areas of research include:

  • Basic and translational studies using a variety of state-of-the-science and emerging approaches
  • Clinical trials evaluating promising pharmacological, psychotherapeutic and neurostimulation-based approaches to challenging psychiatric conditions and substance use disorders
  • Neuroimaging in populations with or at risk for mental illness and substance use disorders
  • Bioinformatics research relevant to behavioral health and mental illness
  • Health disparities and multicultural mental health research

PRIME is committed to:

  • Developing an environment that encourages creative, interdisciplinary research that promotes health and wellness and advances understanding and treatment of mental illness and substance use disorders
  • Supporting a broad base of science and scholarship on areas from neural circuits to mental health policy
  • Engaging meaningfully with and contributing to the diverse communities served by Montefiore and Einstein.

 

Faculty Applicants click here 

Upcoming Events

47th Annual Leadership Conference 

Date: May 31 - June 2, 2019
Brochure 2019 

 

Calendar

Wednesday, June 17, 2020 | 3:00 PM
IP & COVID-19:  Facilitating Innovation & Access To Medicines For Patients
Virtual event, Virtual Event

view calendar

 

Media Spotlight

For Seniors, COVID-19 Sets Off a Pandemic of Despair

Gary Kennedy, M.D., discusses ways to lessen the feelings of isolation, hopelessness, and sadness of older adults during the COVID-19 pandemic “lockdown.” Dr. Kennedy is professor of psychiatry and behavioral sciences at Einstein and director, division of geriatric psychiatry at Montefiore.

Additional coverage of Dr. Kennedy on COVID-19 includes The New York Times

(Thursday, May 28, 2020)

coverage on other stories

 
Click here to log in